ContextVision AB

Research ContextVision AB (CONTX) on Bullrun: market cap NOK 264.51M, P/E 55.9. Explore financials, valuation history, model signals, and stock context.

Key Metrics

Valuation Snapshot

latest market cap is NOK 264.51M; P/E is 55.9.

Peer valuation comparison

Latest P/E is 55.89x versus a Healthcare sector median of 24.46x (128.5% above).

Latest P/E is 55.89x versus a Sweden median of 18.57x (201.0% above).

Five-year financial history

YearRevenueNet incomeFree cash flowGross marginDiluted EPSCashTotal debtEquity
FY2025SEK 110.28MSEK 762.00KSEK 204.00K97.4%0.01SEK 69.83MSEK 12.59MSEK 92.16M
FY2024SEK 130.67MSEK 24.68MSEK 29.28M97.4%n/aSEK 74.37MSEK 10.47MSEK 94.26M
FY2023SEK 132.19MSEK 32.73MSEK 44.05M98.0%n/aSEK 58.14Mn/aSEK 77.83M
FY2022SEK 117.83MSEK 28.79MSEK 24.73M98.0%0.37SEK 41.86Mn/aSEK 66.53M

Valuation history

YearSnapshot dateMarket capP/EDividend yieldAnnual dividend/share
20262026-08-24NOK 264.51M55.9n/an/a

Dividend history

YearDividends/share
FY20230.3 SEK

About ContextVision AB

ContextVision AB (publ), a software company, provides image analysis and imaging for medical systems in South Korea, China, Japan, the United States, and internationally. The company offers image quality solutions for ultrasound, as well as its Rivent platform comprising Rivent, a 2D image enhancement; Rivent Plus, a premium 2D image enhancement product; Rivent 3D, a solution for improving image quality of 3D ultrasound;

Related stock research

Other Healthcare stocks

Frequently asked questions

What is ContextVision AB's market cap?

ContextVision AB's market capitalization is NOK 264.51M.

What is ContextVision AB's P/E ratio?

ContextVision AB's price-to-earnings (P/E) ratio is 55.9.

What does ContextVision AB do?

ContextVision AB (publ), a software company, provides image analysis and imaging for medical systems in South Korea, China, Japan, the United States, and internationally.